Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
co-ceo Processed

Gerald Commissiong & DataMeds AI

8 shared events · Importance 4 · Last updated Sep 21, 2026

Importance
4
Shared Events
8
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard

Gerald Commissiong serves as the Interim Co-CEO of DataMeds AI, where he is actively involved in leading strategic initiatives, acquisitions, and public communications for the company.

77
Business
Gerald Commissiong: As Interim Co-CEO, Commissiong is the public face of the initiative, and his appearance on Fox Business may boost investor confidence in the company's leadership.
DataMeds AI: DataMeds AI is the central company launching the Health Lives Here initiative, which could enhance its market position in health IT and data monetization, though execution risks remain.
Aug 05, 2026 · 6 articles
77
Business
Gerald Commissiong: Gerald Commissiong, Interim Co-CEO of DataMeds AI, is the spokesperson for the rebranding and strategic initiatives.
DataMeds AI: DataMeds AI is the parent company executing the rebranding and strategic initiatives, which may strengthen its healthcare services portfolio and market positioning.
Aug 10, 2026 · 13 articles
73
Business
Gerald Commissiong: Gerald Commissiong, Interim Co-CEO of Wellgistics, provided commentary on the strategic rationale behind the name change and the company's vision.
DataMeds AI: DataMeds AI is the proposed new corporate name for Wellgistics and represents the focus on integrating technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units.
Jun 26, 2026 · 6 articles
71
Business
Gerald Commissiong: As CEO of Tollo and interim co-CEO of DataMeds, Commissiong is a key spokesperson and driver of the partnership.
DataMeds AI: DataMeds AI is a primary partner, leveraging its technology and pharmacy network to launch the Health Lives Here platform, potentially boosting its business and stock.
Sep 08, 2026 · 6 articles
55
Business
Gerald Commissiong: Gerald Commissiong, interim co-CEO, is the spokesperson for the launch, representing the company's leadership and strategic direction.
DataMeds AI: DataMeds AI is the primary company launching Galectovid, which could drive revenue and strengthen its product portfolio. The launch may positively affect its stock price and market perception.
Aug 27, 2026 · 10 articles
55
Business
Gerald Commissiong: As Interim Co-CEO of DataMEDS, Gerald Commissiong highlighted the strategic importance of the acquisition in expanding into oncology and improving patient outcomes.
DataMeds AI: DataMEDS acquired Helomics for $1.5 million, expanding into cancer diagnostics and treatment. The acquisition and subsequent stock surge reflect positive market reception and strategic growth.
Sep 15, 2026 · 7 articles
55
Business
Gerald Commissiong: Interim Co-CEO of DataMeds AI who publicly framed the settlement as clearing the way for the company's healthcare integration and tokenization strategy.
DataMeds AI: The settling party; extinguishes about $19 million in liabilities for $450,000 cash and 364,099 retired shares, strengthening its balance sheet and reducing litigation overhang.
Sep 18, 2026 · 7 articles
55
Business
Gerald Commissiong: Gerald Commissiong, Interim Co-CEO of DataMeds AI, commented on the website launch, the Helomics acquisition closing, the litigation settlement, and plans to soft launch the Health Lives Here app.
DataMeds AI: DataMeds AI is the central actor, launching its new corporate website as part of rebranding and marketing efforts following its Helomics acquisition and litigation settlement. The update is largely promotional and does not materially change its financial position.
Sep 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Gerald Commissiong and DataMeds AI interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.